Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 84
Filtrer
1.
Int J Sport Nutr Exerc Metab ; 34(4): 199-206, 2024 Jul 01.
Article de Anglais | MEDLINE | ID: mdl-38458180

RÉSUMÉ

Carbohydrate (CHO) supplementation during endurance exercise can improve performance. However, it is unclear whether low glycemic index (GI) CHO leads to differential ergogenic and metabolic effects compared with a standard high GI CHO. This study investigated the ergogenic and metabolic effects of CHO supplementation with distinct GIs, namely, (a) trehalose (30 g/hr), (b) isomaltulose (30 g/hr), (c) maltodextrin (60 g/hr), and (d) placebo (water). In this double-blind, crossover, counterbalanced, placebo-controlled study, 13 male cyclists cycled a total of 100 min at varied exercise intensity (i.e., 10-min stages at 1.5, 2.0, and 2.5 W/kg; repeated three times plus two 5-min stages at 1.0 W/kg before and after the protocol), followed by a 20-min time trial on four separated occasions. Blood glucose and lactate (every 20 min), heart rate, and ratings of perceived exertion were collected throughout, and muscle biopsies were taken before and immediately after exercise. The results showed that trehalose improved time-trial performance compared with placebo (total work done 302 ± 39 vs. 287 ± 48 kJ; p = .01), with no other differences between sessions (all p ≥ .07). Throughout the 100-min protocol, blood glucose was higher with maltodextrin compared with the other supplements at all time points (all p < .05). Heart rate, ratings of perceived exertion, muscle glycogen content, blood glucose, and lactate were not different between conditions when considering the 20-min time trial (all p > .05). Trehalose supplementation throughout endurance exercise improved cycling performance and appears to be an appropriate CHO source for exercise tasks up to 2 hr. No ergogenic superiority between the different types of CHO was established.


Sujet(s)
Performance sportive , Cyclisme , Glycémie , Études croisées , Rythme cardiaque , Isomaltose , Acide lactique , Polyosides , Tréhalose , Humains , Mâle , Cyclisme/physiologie , Méthode en double aveugle , Tréhalose/administration et posologie , Tréhalose/pharmacologie , Performance sportive/physiologie , Adulte , Glycémie/métabolisme , Glycémie/effets des médicaments et des substances chimiques , Rythme cardiaque/effets des médicaments et des substances chimiques , Acide lactique/sang , Polyosides/administration et posologie , Polyosides/pharmacologie , Isomaltose/analogues et dérivés , Isomaltose/administration et posologie , Isomaltose/pharmacologie , Compléments alimentaires , Indice glycémique , Endurance physique/effets des médicaments et des substances chimiques , Endurance physique/physiologie , Muscles squelettiques/effets des médicaments et des substances chimiques , Muscles squelettiques/métabolisme , Phénomènes physiologiques nutritionnels du sport , Substances améliorant les performances/administration et posologie , Substances améliorant les performances/pharmacologie , Hydrates de carbone alimentaires/administration et posologie , Jeune adulte , Effort physique/physiologie , Effort physique/effets des médicaments et des substances chimiques , Glycogène/métabolisme
3.
Vitae (Medellín) ; 29(3): 1-12, 2022-08-18. Ilustraciones
Article de Anglais | LILACS, COLNAL | ID: biblio-1393178

RÉSUMÉ

Background: This research was motivated by the complaints of tomato farmers about their crops that quickly rotted before being sold, as well as the many research results (raw materials and methods) that edible coating films could not be applied optimally. Objectives: The research was a practical recommendation by comparing the effectiveness of raw materials (polysaccharides, proteins, and lipids) with the dipping and spray methods. Materials and methods used in the comparison process were the application of Structural Equation Modeling (SEM) with the Partial Least Square (PLS) approach. Results: Dipping has a strong effect (f2 ≥ 0.35; p<0.05), while spray had a moderate effect (f2: 0.15-0.35; p<0.05). Thus, the role of dipping as a mediator was more dominant than spray. Compared to proteins and lipids, polysaccharides had the best effectiveness (ß:0.460-0.584; f2: 0.15-0.35; p<0.05). Conclusion: the three ingredients improved the quality of tomatoes, and the dipping method was easier to apply by farmers than the spray method, which had many obstacles in its application


Antecedentes: esta investigación está motivada por las quejas de los productores de tomate sobre sus cultivos que se pudren rápidamente antes de ser vendidos, así como por los muchos resultados de la investigación (materias primas y métodos) de que las películas de recubrimiento comestibles no se pudieron aplicar de manera óptima. Objetivos: La investigación consiste en recomendaciones prácticas mediante la comparación de la eficacia de las materias primas (polisacáridos, proteínas y lípidos) con los métodos de inmersión y aspersión. Métodos: El método utilizado en el proceso de comparación es la aplicación del modelo de ecuaciones estructurales (SEM) con el enfoque de mínimos cuadrados parciales (PLS). Resultados: La inmersión tiene un efecto fuerte (f2 ≥ 0,35; p<0,05), mientras que la pulverización tiene un efecto moderado (f2: 0,15-0,35; p<0,05). Por lo tanto, el papel de la inmersión como mediador es más dominante que el del rociado. Los polisacáridos tienen la mejor eficacia (ß:0,460-0,584; f2: 0,15-0,35; p<0,05) en comparación con las proteínas y los lípidos. Conclusión: es que los tres ingredientes pueden mejorar la calidad de los tomates, y el método de inmersión es más fácil de aplicar por los agricultores que el método de aspersión, que tiene muchos obstáculos en su aplicación


Sujet(s)
Humains , Qualité alimentaire , Solanum lycopersicum , Immersion , Polyosides/administration et posologie , Efficacité (Effectiveness) , Protéines/administration et posologie , Analyse de structure latente , Lipides/administration et posologie
4.
J Ethnopharmacol ; 286: 114891, 2022 Mar 25.
Article de Anglais | MEDLINE | ID: mdl-34910952

RÉSUMÉ

ETHNOPHARMACOLOGICAL RELEVANCE: The polysaccharides of the millenary mushroom Ganoderma lucidum (GL) have been shown for decades to present anti-tumor activities, but few studies evaluated its importance on cancer stem cells and EMT process. Cancer stem cells (CSC) drive the development of carcinoma and are also involved in cancer treatment failure, being a good target for treatment success. Also, the process of epithelial-mesenchymal transition (EMT) is involved in metastasis and cancer relapse. Besides that, the increasing incidence worldwide of oral squamous cell carcinoma (OSCC) became a public health issue with a high rate of metastasis and poor quality of life for patients during and after treatment. AIM OF THE STUDY: to evaluate G. lucidum polysaccharides (GLPS) in vitro effects on OSCC, focusing on hallmarks associated with tumorigenesis using the SCC-9, a squamous cells carcinoma lineage from the tongue. MATERIALS AND METHODS: SCC-9 cells were treated in vitro for 72h with different GLPS concentrations. The controls cells were maintained with culture media only and cisplatin was used as treatment control. After the treatment period, the cells were evaluated. RESULTS: GLPS treatment changed cell morphology and granularity, delayed migration, decreased colony, and impaired sphere formation, thereby leading to a non-invasive and less proliferative behavior of tumoral cells. Additionally, GLPS downregulated CSC, EMT, and drug sensitivity (ABC) markers. CONCLUSIONS: These results show that the natural product GLPS has the potential to be an important ally for tongue squamous cell carcinoma treatment, bringing the millenary compound to modern therapy, providing a basis for future studies and the improvement of life quality for OSCC patients.


Sujet(s)
Polyosides/pharmacologie , Reishi/composition chimique , Carcinome épidermoïde de la tête et du cou/traitement médicamenteux , Tumeurs de la langue/traitement médicamenteux , Antinéoplasiques/administration et posologie , Antinéoplasiques/isolement et purification , Antinéoplasiques/pharmacologie , Lignée cellulaire tumorale , Cisplatine/pharmacologie , Relation dose-effet des médicaments , Transition épithélio-mésenchymateuse/effets des médicaments et des substances chimiques , Tumeurs de la tête et du cou/traitement médicamenteux , Humains , Cellules souches tumorales/effets des médicaments et des substances chimiques , Polyosides/administration et posologie , Polyosides/isolement et purification , Tumeurs de la langue/anatomopathologie
5.
Mar Drugs ; 19(8)2021 Jul 27.
Article de Anglais | MEDLINE | ID: mdl-34436263

RÉSUMÉ

Marine organisms are a source of active biomolecules with immense therapeutic and nutraceutical potential. Sulfated fucose-rich polysaccharides are present in large quantities in these organisms with important pharmacological effects in several biological systems. These polysaccharides include sulfated fucan (as fucoidan) and fucosylated chondroitin sulfate. The development of these polysaccharides as new drugs involves several important steps, among them, demonstration of the effectiveness of these compounds after oral administration. The oral route is the more practical, comfortable and preferred by patients for long-term treatments. In the past 20 years, reports of various pharmacological effects of these polysaccharides orally administered in several animal experimental models and some trials in humans have sparked the possibility for the development of drugs based on sulfated polysaccharides and/or the use of these marine organisms as functional food. This review focuses on the main pharmacological effects of sulfated fucose-rich polysaccharides, with an emphasis on the antidislipidemic, immunomodulatory, antitumor, hypoglycemic and hemostatic effects.


Sujet(s)
Antinéoplasiques/pharmacologie , Organismes aquatiques , Chondroïtines sulfate/pharmacologie , Polyosides/pharmacologie , Administration par voie orale , Antinéoplasiques/administration et posologie , Chondroïtines sulfate/administration et posologie , Humains , Polyosides/administration et posologie
6.
Food Funct ; 12(9): 3770-3786, 2021 May 11.
Article de Anglais | MEDLINE | ID: mdl-33977950

RÉSUMÉ

Food allergies are known as the public health problem, affecting people of all age groups, but more commonly in babies and children, with consequences for nutritional status and quality of life. The increase in the consumption of healthy foods has consequently led to an increased demand for functional foods with specific health benefits. Thus, the pharmaceutical industry's interest in natural products has grown every time and is therefore considered as an alternative to synthetic drugs. Kefir has been outstanding for several years as promising in the manufacture of various pharmaceutical products, due to its nutritional and therapeutic properties for the treatment of many diseases. Currently, a wide variety of new functional foods are appearing on the market, representing an important segment. Postbiotics, for example, has stood out for being a product with action similar to probiotics, without offering side effects. The kefiran is the postbiotic from kefir that promotes potential beneficial effects on food allergy from the intestinal microbiome to the immune system. In this context, it is necessary to know the main promoting component of this functional effect. This review compiles the benefits that kefir, and especially its postbiotic, kefiran, can bring to food allergy. In addition, it serve as a subsidy for studies on the development of innovative nutraceutical products, including the use of kefiran as an alternative therapy in food allergy.


Sujet(s)
Hypersensibilité alimentaire/thérapie , Aliment fonctionnel , Kéfir , Polyosides , Animaux , Enfant , Enfant d'âge préscolaire , Hypersensibilité alimentaire/complications , Hypersensibilité alimentaire/épidémiologie , Hypersensibilité alimentaire/physiopathologie , Microbiome gastro-intestinal , Humains , Système immunitaire/physiologie , Nourrisson , Kéfir/analyse , Kéfir/microbiologie , Polyosides/administration et posologie , Polyosides/usage thérapeutique , Probiotiques , Facteurs de risque
7.
P R Health Sci J ; 39(4): 311-318, 2020 12.
Article de Anglais | MEDLINE | ID: mdl-33320460

RÉSUMÉ

OBJECTIVE: To test the hypothesis that fermentable fiber prevents Salmonella typhimurium infection-associated symptoms by enhancing innate and adaptive immune system in neonatal pigs. METHODS: Two-d-old piglets (n=120) were randomized to receive either a nutritionally complete sow milk replacer formula (CON), or supplemented with methylcellulose (MCEL-non-fermentable), soy polysaccharides (SPS-moderately fermentable), or fructooligosaccharides (FOS-highly fermentable). On d7, piglets received an oral gavage of S. typhimurium-798, and continued receiving the same diets up to 48h post-infection. Ileal mucosal samples were obtained for further analyses. RESULTS: A reduction in chloride secretion was observed in FOS when compared to other diets (p<0.0003). The number of ileal sulfo-acidomucins was higher (p<0.05) in FOS before infection compared with other diets. NFkB was inhibited in FOS following infection (p<0.05), when compared with CON. IL-1ß expression was increased at 4h post-infection (p<0.05) in CON; however, this response was attenuated in the fiber groups. IL-6 expression was higher (p<0.05) in CON post- infection, higher in SPS at 24h (p<0.05), but unchanged in MCEL and FOS when compared to pre-infection values. FOS had a higher expression of neutrophil-chemoattractant IL-8 before infection (p<0.05) compared to other groups. CONCLUSION: The reduction in chloride secretion, proinflammatory cytokines expression and NFkB activation, and increased number of sulfo-acidomucins, and IL-8 expression in the fiber groups, indicates that the degree of fermentability impacts the innate and adaptive immune system, and could be the mechanisms by which dietary fibers reduce S. typhimurium infection-associated-symptoms in neonatal pigs and apply these results to infants.


Sujet(s)
Fibre alimentaire/administration et posologie , Fermentation , Oligosaccharides/administration et posologie , Salmonelloses/prévention et contrôle , Immunité acquise/immunologie , Animaux , Animaux nouveau-nés , Cytokines/immunologie , Fibre alimentaire/pharmacologie , Immunité innée/immunologie , Méthylcellulose/administration et posologie , Méthylcellulose/pharmacologie , Oligosaccharides/pharmacologie , Polyosides/administration et posologie , Polyosides/pharmacologie , Répartition aléatoire , Salmonelloses/immunologie , Salmonella typhimurium/isolement et purification , Glycine max/composition chimique , Suidae
8.
Nutrients ; 12(12)2020 Dec 11.
Article de Anglais | MEDLINE | ID: mdl-33322280

RÉSUMÉ

The rating of perceived exertion (RPE) indicates the feeling of fatigue. However, hypoxia worsens the condition and can worsen RPE. We evaluated whether carbohydrate and glutamine supplementation alters RPE and physiological markers in running at 70% peak oxygen uptake until exhaustion in a simulated altitude of 4500 m. Nine volunteers underwent three running tests at 70% peak oxygen uptake until exhaustion: (1) hypoxia and placebo, (2) hypoxia and 8% maltodextrin, and (3) hypoxia after six days of glutamine supplementation (20 g/day) and 8% maltodextrin. The exercise and supplementation were randomized and double-blinded. Lactate, heart rate, haemoglobin O2 saturation (SpO2%), and RPE (6-20 scale) were analyzed at the 15th and 30th min. The level of significance was set at p ≤ 0.05. SpO2% decreased at the 15th and 30th minutes compared to resting in placebo, carbohydrate, and glutamine supplementation. RPE increased at the 30th minute compared to the 15th minute in placebo and carbohydrate supplementation; however, there was no difference in the glutamine supplementation condition. Heart rate and lactate increased after the 15th and 30th minutes compared to resting, similar to the three conditions studied. We conclude that previous supplementation with glutamine and carbohydrate during intense exercise in hypoxia similar to 4500 m can attenuate the increase in RPE by the increase in glycemia and can be a useful strategy for people who exercise in these conditions.


Sujet(s)
Mal de l'altitude/psychologie , Hydrates de carbone alimentaires/administration et posologie , Compléments alimentaires , Glutamine/administration et posologie , Perception/effets des médicaments et des substances chimiques , Effort physique/physiologie , Course à pied/physiologie , Adulte , Altitude , Mal de l'altitude/physiopathologie , Gazométrie sanguine , Méthode en double aveugle , Volontaires sains , Rythme cardiaque/physiologie , Humains , Acide lactique/sang , Mâle , Consommation d'oxygène/physiologie , Polyosides/administration et posologie , Facteurs temps
9.
Nutrients ; 12(4)2020 Apr 13.
Article de Anglais | MEDLINE | ID: mdl-32295092

RÉSUMÉ

Maternal bacteria are shared with infants via breastfeeding. Prebiotics modulate the gut microbiota, promoting health benefits. We investigated whether the maternal diet supplementation with a prebiotic (fructooligosaccharides, FOS) could influence the milk microbiota. Twenty-eight lactating women received 4.5 g of fructooligosaccharides + 2 g of maltodextrin (FOS group) and twenty-five received 2 g of maltodextrin (placebo group) for 20 days. Breast-milk samples were taken before and after the intervention. The DNA from samples was used for 16S rRNA sequencing. No statistical differences between the groups were found for the bacterial genera after the intervention. However, the distances of the trajectories covered by paired samples from the beginning to the end of the supplementation were higher for the FOS group (p = 0.0007) indicating greater changes in milk microbiota compared to the control group. Linear regression models suggested that the maternal age influenced the response for FOS supplementation (p = 0.02). Interestingly, the pattern of changes to genus abundance upon supplementation was not shared between mothers. We demonstrated that manipulating the human milk microbiota through prebiotics is possible, and the maternal age can affect this response. .


Sujet(s)
Allaitement naturel , Compléments alimentaires , Microbiome gastro-intestinal , Âge maternel , Lait humain/microbiologie , Oligosaccharides/administration et posologie , Polyosides/administration et posologie , Prébiotiques/administration et posologie , Adolescent , Adulte , Femelle , Humains , Nourrisson , Nouveau-né , Mâle , Méthode en simple aveugle , Jeune adulte
10.
Semina Ci. agr. ; 41(06,supl. 2): 3093-3106, 2020. graf
Article de Anglais | VETINDEX | ID: vti-31652

RÉSUMÉ

The pinhão shows high nutritional value; however, its consumption is still low owing to the long cooking time required because it is hard to peel, and it is susceptible to sprouting, larval infestation, and fungal contamination. Thus, this study aimed to evaluate the storage stability of minimally processed pinhão by using edible coatings with antimicrobial characteristics. The pinhões were subjected to minimal processing with the following treatments: Treatment A - control; Treatment B - chitosan; Treatment C - xanthan gum and clove essential oil. After drying, they were packed in polyethylene terephthalate and stored at 4 °C for nine days. The pinhões were analyzed for mass loss, total acidity, reducing sugars, vitamin C, color, firmness, respiratory rate, sensory characteristics, and microbial growth. In general, no differences were observed in mass loss, reducing sugars, and oxygen concentrations of the pinhões after any treatment. In addition, we observed a reduction in acidity and carbon dioxide concentrations, maintenance of color parameters, and the absence of growth of thermotolerant coliforms and coagulase positive Staphylococcus. Although the minimal processing did not increase the respiratory rate of pinhões, it did not stop the process of seed maturation. Of the coatings evaluated, chitosan coating of the pinhões was associated with a higher content of vitamin C as well as a lower number of psychrotrophic microorganisms. The coatings did not influence the taste and aroma of the minimally processed pinhões.(AU)


O pinhão apresenta alto valor nutricional, entretanto seu consumo ainda é pouco expressivo devido ao longo tempo de cocção, por apresentar um difícil descasque, ser susceptível ao processo de brotamento, infestação por larvas e deterioração fúngica. Assim, o presente trabalho teve por objetivo avaliar a conservação de pinhões minimamente processados por meio de revestimentos comestíveis com características antimicrobianas. Os pinhões foram submetidos ao processamento mínimo e após aos diferentes tratamentos: Tratamento A - controle; Tratamento B - quitosana; Tratamento C - xantanae óleo essencial de cravo-da-índia. Após, foram secos sob ventilação forçada, acondicionados em embalagem de Polietileno Tereftalato (PET) e armazenados a 4 ºC, durante 9 dias. Foram realizadas avaliações de perda de massa, acidez total titulável, açúcares redutores, vitamina C, firmeza, cor, taxa respiratória, análise sensorial e microbiológica. De uma forma geral, independente do tratamento, pôde se observar comportamento semelhante nas características dos pinhões, em relação ao aumento da perda de massa, dos açúcares redutores, da concentração de oxigênio e da deterioração fisiológica. Além disso, foi observada a redução da acidez e da concentração de dióxido de carbono, bem como a manutenção dos parâmetros de cor e a ausência de crescimento de coliformes termotolerantes e Staphylococcus coagulase positiva. O processamento mínimo não elevou a taxa respiratória dos pinhões, porém não freou o processo de maturação das sementes. Dos revestimentos avaliados, a quitosana possibilitou a obtenção de pinhões com maior teor de vitamina C e contagem de microrganismos psicrotróficos. Os revestimentos não influenciaram no sabor e aroma dos pinhões minimamente processados.(AU)


Sujet(s)
Chitosane/administration et posologie , Huile de clou de girofle/administration et posologie , Polyosides/administration et posologie
11.
Semina ciênc. agrar ; 41(06,supl. 2): 3093-3106, 2020. graf
Article de Anglais | VETINDEX | ID: biblio-1501670

RÉSUMÉ

The pinhão shows high nutritional value; however, its consumption is still low owing to the long cooking time required because it is hard to peel, and it is susceptible to sprouting, larval infestation, and fungal contamination. Thus, this study aimed to evaluate the storage stability of minimally processed pinhão by using edible coatings with antimicrobial characteristics. The pinhões were subjected to minimal processing with the following treatments: Treatment A - control; Treatment B - chitosan; Treatment C - xanthan gum and clove essential oil. After drying, they were packed in polyethylene terephthalate and stored at 4 °C for nine days. The pinhões were analyzed for mass loss, total acidity, reducing sugars, vitamin C, color, firmness, respiratory rate, sensory characteristics, and microbial growth. In general, no differences were observed in mass loss, reducing sugars, and oxygen concentrations of the pinhões after any treatment. In addition, we observed a reduction in acidity and carbon dioxide concentrations, maintenance of color parameters, and the absence of growth of thermotolerant coliforms and coagulase positive Staphylococcus. Although the minimal processing did not increase the respiratory rate of pinhões, it did not stop the process of seed maturation. Of the coatings evaluated, chitosan coating of the pinhões was associated with a higher content of vitamin C as well as a lower number of psychrotrophic microorganisms. The coatings did not influence the taste and aroma of the minimally processed pinhões.


O pinhão apresenta alto valor nutricional, entretanto seu consumo ainda é pouco expressivo devido ao longo tempo de cocção, por apresentar um difícil descasque, ser susceptível ao processo de brotamento, infestação por larvas e deterioração fúngica. Assim, o presente trabalho teve por objetivo avaliar a conservação de pinhões minimamente processados por meio de revestimentos comestíveis com características antimicrobianas. Os pinhões foram submetidos ao processamento mínimo e após aos diferentes tratamentos: Tratamento A - controle; Tratamento B - quitosana; Tratamento C - xantanae óleo essencial de cravo-da-índia. Após, foram secos sob ventilação forçada, acondicionados em embalagem de Polietileno Tereftalato (PET) e armazenados a 4 ºC, durante 9 dias. Foram realizadas avaliações de perda de massa, acidez total titulável, açúcares redutores, vitamina C, firmeza, cor, taxa respiratória, análise sensorial e microbiológica. De uma forma geral, independente do tratamento, pôde se observar comportamento semelhante nas características dos pinhões, em relação ao aumento da perda de massa, dos açúcares redutores, da concentração de oxigênio e da deterioração fisiológica. Além disso, foi observada a redução da acidez e da concentração de dióxido de carbono, bem como a manutenção dos parâmetros de cor e a ausência de crescimento de coliformes termotolerantes e Staphylococcus coagulase positiva. O processamento mínimo não elevou a taxa respiratória dos pinhões, porém não freou o processo de maturação das sementes. Dos revestimentos avaliados, a quitosana possibilitou a obtenção de pinhões com maior teor de vitamina C e contagem de microrganismos psicrotróficos. Os revestimentos não influenciaram no sabor e aroma dos pinhões minimamente processados.


Sujet(s)
Polyosides/administration et posologie , Chitosane/administration et posologie , Huile de clou de girofle/administration et posologie
12.
Adv Rheumatol ; 60: 26, 2020. tab, graf
Article de Anglais | LILACS | ID: biblio-1130806

RÉSUMÉ

Abstract Background: Injection of Hylan G-F20 (HY) into joints may provoke local flares, which mechanisms may involve reaction to protein contaminants. We have previously developed a protein-free saline-soluble galactomannan derived from guar gum (GM) that displays both analgesia and chondroprotection in experimental osteoarthritis (OA). We now demonstrate that both GM and Hylan G-F20 (HY) promote mild synovitis with cytokine release after intra-articular injection. Methods: Mice received 100 μg/25 μL GM or HY or saline into the knees. Joint pain was evaluated using von Frey test; cell influx, interleukin (IL)-1, IL-6, and CXCL-1 (pg/mL) levels were assessed in joint lavage at 6 h. Synovia were excised for histopathology. Results: Neither GM nor HY after being given into mice knee joints induced pain albeit promoting mild cell influx into joint washings as well as mild synovitis at histology, with no damage to the underlying cartilage. HY but not GM promoted IL-1 release into mice joints. Both compounds induced IL-6 and CXCL-1 release. Conclusion: Intra-articular injection of HY or GM promote acute transient synovitis whilst not provoking detectable significant joint damage. Local administration of these polysaccharides induces acute intra-articular release of inflammatory cytokines, which may account for joint flares following viscosupplementation.(AU)


Sujet(s)
Animaux , Souris , Arthrose/physiopathologie , Polyosides/administration et posologie , Viscosupplémentation/instrumentation , Acide hyaluronique/administration et posologie
13.
Rev. chil. nutr ; 46(6): 768-775, dic. 2019. tab
Article de Anglais | LILACS | ID: biblio-1058140

RÉSUMÉ

ABSTRACT Bioactive compounds are substances present in low doses in foods mostly from the plant kingdom. Their consumption can influence physiological or cellular processes and has a beneficial effect on health. Fucoidans and beta-glucans are bioactive compounds that share the characteristic of being carbohydrates of the polysaccharide type, specifically of the soluble fiber kind. These compounds can be found in foods available in Chile and part of the Chilean diet; foods include, brown algae and some cereals. The concentration of these compounds in foods is variable, and depends on factors like season, cultivation, germination, and method of preparation and conservation. The current literature shows the potential beneficial effects of fucoidan and beta-glucans compounds in human health, which include: anticoagulant, immuno-modulator and antidiabetic and immunomodulating. The effects depend, among other factors, on their bioavailability and molecular weight. The objective of this review was to describe the potential beneficial effects of these bioactive compounds, analyze their characteristics and properties, and provide consumption recommendations that may lead to achieving the expected beneficial effects. To that end, relevant and recent scientific literature was analyzed.


RESUMEN Los compuestos bioactivos corresponden a aquellos elementos presentes en los alimentos, que influyen en procesos fisiológicos o celulares, cuyo consumo produce un efecto beneficioso para la salud, encontrándose en alimentos principalmente del reino vegetal y cuyas concentraciones en los alimentos son en mínimas dosis. Los fucoidanos y los beta-glucanos, son compuestos bioactivos que comparten la característica de ser un carbohidrato, de tipo polisacárido, específicamente fibra de tipo soluble, encontrándose presente en alimentos disponibles en nuestro país y que son parte de nuestra dieta, como las algas pardas y algunos cereales. La concentración de estos compuestos en los alimentos, es fluctuante y depende de factores como la estacionalidad, cultivo, germinación, método de preparación y conservación. En la bibliografía actual, se evidencian los potenciales efectos beneficiosos de fucanos y beta-glucanos para la salud humana como anticoagulante, antidiabético e inmunomodulador, la intensidad de estos efectos dependen de su biodisponibilidad y del peso molecular. El objetivo de esta revisión fué profundizar respecto a los potenciales efectos beneficiosos de estos compuestos bioactivos, analizar sus características, propiedades, además de relacionar una recomendación de consumo que permita alcanzar los efectos beneficiosos esperados. Para ello se analizó la bibliografía científica atingente, relevante y reciente.


Sujet(s)
Humains , Polyosides/administration et posologie , Polyosides/composition chimique , bêta-Glucanes/administration et posologie , bêta-Glucanes/composition chimique , Fibre alimentaire/administration et posologie , Composés phytochimiques/administration et posologie , Composés phytochimiques/composition chimique , Facteurs immunologiques/administration et posologie , Facteurs immunologiques/composition chimique
14.
mBio ; 10(2)2019 04 02.
Article de Anglais | MEDLINE | ID: mdl-30940711

RÉSUMÉ

Cryptococcus neoformans is an encapsulated fungal pathogen that causes meningoencephalitis. There are no prophylactic tools for cryptococcosis. Previously, our group showed that a C. neoformans mutant lacking the gene encoding sterylglucosidase (Δsgl1) induced protection in both immunocompetent and immunocompromised murine models of cryptococcosis. Since sterylglucosidase catalyzes degradation of sterylglucosides (SGs), accumulation of this glycolipid could be responsible for protective immunity. In this study, we analyzed whether the activity of SGs is sufficient for the protective effect induced by the Δsgl1 strain. We observed that the accumulation of SGs impacted several properties of the main polysaccharide that composes the fungal capsule, glucuronoxylomannan (GXM). We therefore used genetic manipulation to delete the SGL1 gene in the acapsular mutant Δcap59 to generate a double mutant (strain Δcap59/Δsgl1) that was shown to be nonpathogenic and cleared from the lung of mice within 7 days post-intranasal infection. The inflammatory immune response triggered by the Δcap59/Δsgl1 mutant in the lung differed from the response seen with the other strains. The double mutant did not induce protection in a vaccination model, suggesting that SG-related protection requires the main capsular polysaccharide. Finally, GXM-containing extracellular vesicles (EVs) enriched in SGs delayed the acute lethality of Galleria mellonella against C. neoformans infection. These studies highlighted a key role for GXM and SGs in inducing protection against a secondary cryptococcal infection, and, since EVs notoriously contain GXM, these results suggest the potential use of Δsgl1 EVs as a vaccination strategy for cryptococcosis.IMPORTANCE The number of deaths from cryptococcal meningitis is around 180,000 per year. The disease is the second leading cause of mortality among individuals with AIDS. Antifungal treatment is costly and associated with adverse effects and resistance, evidencing the urgency of development of both therapeutic and prophylactic tools. Here we demonstrate the key roles of polysaccharide- and glycolipid-containing structures in a vaccination model to prevent cryptococcosis.


Sujet(s)
Cryptococcose/prévention et contrôle , Cryptococcus neoformans/immunologie , Vaccins antifongiques/immunologie , Glycolipides/immunologie , Polyosides/immunologie , Animaux , Cryptococcus neoformans/génétique , Modèles animaux de maladie humaine , Vésicules extracellulaires/immunologie , Vaccins antifongiques/administration et posologie , Délétion de gène , Glycolipides/administration et posologie , Lepidoptera , Polyosides/administration et posologie , Analyse de survie
15.
R. bras. Ci. avíc. ; 21(3): eRBCA-2018-0945, 2019. tab, graf
Article de Anglais | VETINDEX | ID: vti-25669

RÉSUMÉ

To investigate the hypothesis that APS can attenuate E. coli-induced microvascular dysfunction in chicken intestine, 60 0-day old male chickens were divided into three groups with 5 replications of 4 chicks. Chicken in the APS group were treated with 15 mg APS daily while the others were given 0 mg APS for 6 days. Then all 7-day old chicken were injected intraperitoneally by E. coli, except for the chicken in the control group. After 4 h, all chickens intestinal samples were collected to detect gene expressions involved in inflammatory factors and adhesion molecules. Results showed that APS attenuated the signs of edema and hemorrhage in 7-day old chicken intestinal mucosa which were induced by E. coli injection. Consistently, APS significantly reduced the increasing mRNA levels of inflammatory factors such as Tumor necrosis factor-a (TNF-a), interleukin (IL) -1 and inducible nitric oxide synthase (iNOS) (p 0.05), the same results were observed in vascular adhesion molecules such as E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1). Moreover, we observed that APS supplementation in water suppressed significantly (p 0.05) the decline of reparative factors such as epithelial growth factor (EGF) and basic fibroblast growth factor (bFGF) in E. coli injected group. Furthermore, supplementation with APS substantially blocked (p 0.05) the increase in Toll-like receptor-4 (TLR4) and Nuclear factor (NF)-B mRNA abundance (p=0.087) induced by E. coli infection. This study indicated that microvascular injured chicken intestine induced by E. coli would be attenuated with feeding APS, and the mechanism of repairing were probably mediated through TLR4-NF-B signal pathways.(AU)


Sujet(s)
Animaux , Poulets/microbiologie , Polyosides/administration et posologie , Polyosides/analyse , Escherichia coli , Astragalus , Microvaisseaux/traumatismes
16.
Rev. bras. ciênc. avic ; 21(3): eRBCA, 2019. tab, graf
Article de Anglais | VETINDEX | ID: biblio-1490680

RÉSUMÉ

To investigate the hypothesis that APS can attenuate E. coli-induced microvascular dysfunction in chicken intestine, 60 0-day old male chickens were divided into three groups with 5 replications of 4 chicks. Chicken in the APS group were treated with 15 mg APS daily while the others were given 0 mg APS for 6 days. Then all 7-day old chicken were injected intraperitoneally by E. coli, except for the chicken in the control group. After 4 h, all chickens intestinal samples were collected to detect gene expressions involved in inflammatory factors and adhesion molecules. Results showed that APS attenuated the signs of edema and hemorrhage in 7-day old chicken intestinal mucosa which were induced by E. coli injection. Consistently, APS significantly reduced the increasing mRNA levels of inflammatory factors such as Tumor necrosis factor-a (TNF-a), interleukin (IL) -1 and inducible nitric oxide synthase (iNOS) (p 0.05), the same results were observed in vascular adhesion molecules such as E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1). Moreover, we observed that APS supplementation in water suppressed significantly (p 0.05) the decline of reparative factors such as epithelial growth factor (EGF) and basic fibroblast growth factor (bFGF) in E. coli injected group. Furthermore, supplementation with APS substantially blocked (p 0.05) the increase in Toll-like receptor-4 (TLR4) and Nuclear factor (NF)-B mRNA abundance (p=0.087) induced by E. coli infection. This study indicated that microvascular injured chicken intestine induced by E. coli would be attenuated with feeding APS, and the mechanism of repairing were probably mediated through TLR4-NF-B signal pathways.


Sujet(s)
Animaux , Escherichia coli , Poulets/microbiologie , Polyosides/administration et posologie , Polyosides/analyse , Astragalus , Microvaisseaux/traumatismes
17.
Int J Pharm ; 551(1-2): 121-132, 2018 Nov 15.
Article de Anglais | MEDLINE | ID: mdl-30218826

RÉSUMÉ

This study evaluated the in vivo anticonvulsant effect of a spray-dried powder for reconstitution containing phenytoin-loaded lipid-core nanocapsules. The effect of chitosan coating on redispersibility, gastrointestinal stability, and drug release from nanoparticles was evaluated during the development of the powders. Maltodextrin was used as adjuvant in the spray-drying process. Chitosan coating played an important role in redispersibility, and large particles (>100 µm) were obtained using the highest concentration of solids in the feed. However, after aqueous redispersion, volume-based particle size was reduced to about 1 µm. The release of nanoparticles from the surface of the spherical microagglomerates (roundness index = 0.75) was confirmed by SEM analysis. Powders reconstituted in water recovered partially the nanometric properties of the original suspensions and were stable for 24 h. Phenytoin-loaded chitosan-coated nanocapsules and their redispersed powders have good gastrointestinal stability, and are able to control drug release in simulated gastric and intestinal fluids. Besides that, the reconstituted powder containing chitosan-coated nanocapsules exhibited improved anticonvulsant activity against seizures induced by pilocarpine in mice, compared to the non-encapsulated drug, representing an important approach in anticonvulsant treatments for children and adults.


Sujet(s)
Anticonvulsivants/administration et posologie , Nanocapsules/administration et posologie , Phénytoïne/administration et posologie , Animaux , Anticonvulsivants/composition chimique , Chitosane/administration et posologie , Chitosane/composition chimique , Dessiccation , Préparation de médicament , Libération de médicament , Femelle , Mâle , Souris de lignée C57BL , Nanocapsules/composition chimique , Phénytoïne/composition chimique , Pilocarpine , Polyosides/administration et posologie , Polyosides/composition chimique , Poudres , Crises épileptiques/induit chimiquement , Crises épileptiques/traitement médicamenteux
18.
Int Immunopharmacol ; 62: 96-108, 2018 Sep.
Article de Anglais | MEDLINE | ID: mdl-29990699

RÉSUMÉ

Ifosfamide (IFO) is an antineoplastic drug that is commonly used to treat gynecological and breast cancers. Hemorrhagic cystitis (HC) is a common side effect associated with IFO injection, which courses with neutrophil accumulation and affects 6-50% of patients depending on dose intensity. Here, we investigated the role of neutrophils in this inflammatory process. Female Swiss mice (n = 8/group) were injected with saline, IFO (400 mg/kg, i.p.), fucoidan (a P- and L-selectins inhibitor, 100 mg/kg, i.v.) or IFO + fucoidan (1-100 mg/kg) alone or combined with mesna (80 mg/kg i.p.). Another group of mice received anti-Ly6G antibody (500 µg/mouse, once daily for 2 days) for neutrophil depletion before IFO injection. In another experimental setting, animals received granulocyte colony-stimulating factor (G-CSF, 400 µg/kg), IFO (200 mg/kg), G-CSF (25-400 µg/kg, for 5 days) + IFO (200 mg/kg, i.p.) or fucoidan + G-CSF + IFO. Bladder injury was evaluated 12 h after IFO injection. IFO 400 mg/kg significantly increased visceral hyperalgesia, bladder edema, hemorrhage, vascular permeability, MPO, IL-1ß and IL-6 tissue levels, and COX-2 immunostaining and expression versus the saline group (P < 0.05). Conversely, fucoidan (100 mg/kg) significantly attenuated these parameters compared to IFO-injected mice (P < 0.05). Additionally, fucoidan potentiated mesna protective effect when compared with IFO + mesna group (P < 0.05). Accordingly, neutrophil depletion with anti-Ly6G reduced inflammatory parameters and bladder injury compared to IFO (P < 0.05). In contrast, G-CSF enhanced IFO (200 mg/kg)-induced HC, which was significantly attenuated by treatment with fucoidan (P < 0.05). Therefore, neutrophils contribute to the pathogenesis of HC.


Sujet(s)
Antinéoplasiques alcoylants/effets indésirables , Cystite/induit chimiquement , Hémorragie/induit chimiquement , Ifosfamide/effets indésirables , Infiltration par les neutrophiles/effets des médicaments et des substances chimiques , Agents protecteurs/usage thérapeutique , Animaux , Cystite/immunologie , Cystite/anatomopathologie , Cystite/prévention et contrôle , Association de médicaments , Femelle , Hémorragie/immunologie , Hémorragie/anatomopathologie , Hémorragie/prévention et contrôle , Mesna/administration et posologie , Mesna/usage thérapeutique , Souris , Polyosides/administration et posologie , Polyosides/usage thérapeutique , Agents protecteurs/administration et posologie
19.
Nutr J ; 16(1): 24, 2017 Apr 20.
Article de Anglais | MEDLINE | ID: mdl-28427403

RÉSUMÉ

BACKGROUND: A strategy of limited preoperative fasting, with carbohydrate (CHO) loading and intraoperative infusion of omega-3 polyunsaturated fatty acids (ω-3 PUFA), has seldom been tried in cardiovascular surgery. Brief fasting, followed by CHO intake 2 h before anesthesia, may improve recovery from CABG procedures and lower perioperative vasoactive drug requirements. Infusion of ω-3 PUFA may reduce occurrences of postoperative atrial fibrillation (POAF) and shorten hospital stays. The aim of this study was to assess morbidity (especially POAF) in ICU patients after coronary artery bypass grafting (CABG)/cardiopulmonary bypass (CPB) in combination, if preoperative fasts are curtailed in favor of CHO loading, and ω-3 PUFA are infused intraoperatively. METHODS: Fifty-seven patients undergoing CABG were randomly assigned to receive 12.5% maltodextrin (200 ml, 2 h before anesthesia), without infusing ω-3 PUFA (CHO, n = 14); water (200 ml, 2 h before anesthesia), without infusing ω-3 PUFA (controls, n = 14); 12.5% maltodextrin (200 ml, 2 h before anesthesia) plus intraoperative ω-3 PUFA (0.2 mcg/kg) (CHO + W3, n = 15); or water (200 ml, 2 h before anesthesia) plus intraoperative ω-3 PUFA (0.2 mcg/kg) (W3, n = 14). Perioperative clinical variables and mortality were analyzed, examining the incidence of POAF, as well as the need for inotropic vasoactive drugs during surgery and in ICU. RESULTS: Two deaths occurred (3.5%), but there were no instances of bronchoaspiration and mediastinitis. Neither ICU stays nor total postoperative stays differed by group (P > 0.05). Patients given preoperative CHO loads (CHO and CHO + W3 groups) experienced fewer instances of hospital infection (RR = 0.29, 95%CI 0.09-0.94; P = 0.023) and were less reliant on vasoactive amines during surgery (RR = 0.60, 95% CI 0.38-0.94; P = 0.020). Similarly, the number of patients requiring vasoactive drugs while recovering in ICU differed significantly by group (P = 0.008), showing benefits in patients given CHO loads. The overall incidence of POAF was 29.8% (17/57), differing significantly by group (P = 0.009). Groups given ω-3 PUFA (W3 and CHO + W3 groups) experienced significantly fewer instances of POAF (RR = 4.83, 95% CI 1.56-15.02; P = 0.001). CONCLUSION: Preoperative curtailment of fasting was safe in this cohort. When implemented in conjunction with CHO loading and infusion of ω-3 PUFA during surgery, expedited recovery from CABG with CPB was observed. TRIAL REGISTRATION: NCT: 03017001.


Sujet(s)
Fibrillation auriculaire/épidémiologie , Pontage aortocoronarien/mortalité , Infection croisée/épidémiologie , Hydrates de carbone alimentaires/administration et posologie , Acides gras omega-3/administration et posologie , Complications postopératoires/épidémiologie , Sujet âgé , Fibrillation auriculaire/prévention et contrôle , Indice de masse corporelle , Poids , Infection croisée/prévention et contrôle , Relation dose-effet des médicaments , Méthode en double aveugle , Détermination du point final , Femelle , Humains , Incidence , Unités de soins intensifs , Durée du séjour , Mâle , Adulte d'âge moyen , Morbidité , Soins périopératoires , Polyosides/administration et posologie , Complications postopératoires/prévention et contrôle , Soins préopératoires , Résultat thérapeutique
20.
Arq. gastroenterol ; Arq. gastroenterol;54(1): 33-36, Jan.-Mar. 2017. tab, graf
Article de Anglais | LILACS | ID: biblio-838818

RÉSUMÉ

ABSTRACT BACKGROUND Abbreviation of preoperative fasting to 2 hours with maltodextrin (CHO)-enriched beverage is a safe procedure and may enhance postoperative recovery. Addition of glutamine (GLN) to CHO beverages may include potential benefits to the metabolism. However, by adding a nitrogenous source to CHO beverages, gastric emptying may be delayed and increase the risk of bronchoaspiration during anesthesia. OBJECTIVE In this study of safety, we aimed at investigating the residual gastric volume (RGV) 2 hours after the intake of either CHO beverage alone or CHO beverage combined with GLN. METHODS We performed a randomized, crossover clinical trial. We assessed RGV by means of abdominal ultrasonography (US) in 20 healthy volunteers (10 males and 10 females) after an overnight fast of 8 hours. Then, they were randomized to receive 600 mL (400 mL immediately after US followed by another 200 mL 2 hours afterwards) of either CHO (12.5% maltodextrin) or CHO-GLN (12.5% maltodextrin plus 15 g GLN). Two sequential US evaluations were done at 120 and 180 minutes after ingestion of the second dose. The interval of time between ingestion of the two types of beverages was 2 weeks. RESULTS The mean (SD) RGV observed after 8 hours fasting (13.56±13.25 mL) did not statistically differ (P>0.05) from the RGV observed after ingesting CHO beverage at both 120 (16.32±11.78 mL) and 180 minutes (14.60±10.39 mL). The RGV obtained at 120 (15.63±18.83 mL) and 180 (13.65±10.27 mL) minutes after CHO-GLN beverage also was not significantly different from the fasting condition. CONCLUSION The RGV at 120 and 180 minutes after ingestion of CHO beverage combined with GLN is similar to that observed after an overnight fast.


RESUMO CONTEXTO A abreviação do jejum pré-operatório com solução enriquecida com maltodextrina é segura, recomendada por sociedades de anestesiologia e acelera a recuperação pós-operatória. A associação de glutamina à maltodextrina resultaria em benefícios metabólicos, porém, esta associação pode alterar o volume do resíduo gástrico e consequentemente risco de broncoaspiração. OBJETIVO Avaliaremos, usando a ultrassonografia, o volume residual gástrico em jejum de 8 horas e após 120 e 180 minutos da ingestão de solução de maltodextrina isolada ou associada a 15 g de glutamina. MÉTODOS Estudo clínico, randomizado, duplo cego e cruzado. Vinte voluntários saudáveis, sendo 10 do sexo masculino e 10 do sexo feminino, foram submetidos a seguinte sequência de avaliação, independente da solução usada. Os voluntários foram avaliados em jejum de 8 horas, 120 e 180 minutos após a ingestão da solução de maltodextrina 12,5% e 120 e 180 após a ingestão da solução de maltodextrina 12,5% mais 15 g de glutamina. RESULTADOS Não houve diferença estatisticamente significativa entre os volumes obtidos após jejum de 8 horas (13,56 mL) e os obtidos após 120 (16,32 mL) e 180 minutos (14,60 mL) da ingestão da solução de maltodextrina 12,5% (P>0,05). Para a solução enriquecida com glutamina, os volumes obtidos após 120 minutos (15,63 mL) e 180 minutos (13,65 mL) também não demostraram diferença estatisticamente significativa quando comparados ao jejum (P>0,05). CONCLUSÃO O volume residual gástrico após 120 e 180 minutos da ingestão das soluções de maltodextrina a 12,5% isolada ou associada a 15 g de glutamina é semelhante ao observado em jejum.


Sujet(s)
Humains , Mâle , Femelle , Adolescent , Adulte , Jeune adulte , Polyosides/administration et posologie , Estomac/ultrastructure , Vidange gastrique/physiologie , Glutamine/administration et posologie , Polyosides/pharmacocinétique , Valeurs de référence , Estomac/physiologie , Facteurs temps , Boissons , Répartition aléatoire , Méthode en double aveugle , Études croisées , Volontaires sains , Glutamine/pharmacocinétique
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE